Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Altimmune (ALT) over the last 12 years, with Q3 2025 value amounting to 0.48%.

  • Altimmune's Return on Invested Capital changed N/A to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year change of. This contributed to the annual value of 0.45% for FY2022, which is N/A changed from last year.
  • As of Q3 2025, Altimmune's Return on Invested Capital stood at 0.48%.
  • Altimmune's 5-year Return on Invested Capital high stood at 0.25% for Q1 2021, and its period low was 0.73% during Q1 2025.
  • Moreover, its 3-year median value for Return on Invested Capital was 0.45% (2022), whereas its average is 0.45%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 3200bps in 2021, then tumbled by -700bps in 2022.
  • Quarter analysis of 3 years shows Altimmune's Return on Invested Capital stood at 0.37% in 2021, then fell by -21bps to 0.45% in 2022, then dropped by -6bps to 0.48% in 2025.
  • Its Return on Invested Capital was 0.48% in Q3 2025, compared to 0.59% in Q2 2025 and 0.73% in Q1 2025.